Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_assertion type Assertion NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_head.
- NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_assertion description "[Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_provenance.
- NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_assertion evidence source_evidence_literature NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_provenance.
- NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_assertion SIO_000772 24012456 NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_provenance.
- NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_assertion wasDerivedFrom befree-2016 NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_provenance.
- NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_assertion wasGeneratedBy ECO_0000203 NP1108297.RAX17NWuvquohLgpaoGuvx8UVO4hHcUXapRqZZe7mLvyA130_provenance.